Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T F Woolf

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 1, 1996
The effect of cytochromes P4501A induction and inhibition on the disposition of the cognition activator tacrine in rat hepatic preparationsS Bezek, M Kukan, W F Pool, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 1, 1994
Metabolic disposition of tacrine in primary suspensions of rat hepatocyte and in single-pass perfused liver: in vitro/in vivo comparisonsM Kukan, S Bezek, W F Pool, et al.
Biochemical Pharmacology|July 6, 1993
An investigation into the formation of stable, protein-reactive and cytotoxic metabolites from tacrine in vitro. Studies with human and rat liver microsomesS Madden, T F Woolf, W F Pool, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1990
Metabolic disposition of trimetrexate, a nonclassical dihydrofolate reductase inhibitor, in rat and dogB K Wong, T F Woolf, T Chang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1994
Stereoselective hydroxylation of tacrine in rats and humansW D Hooper, W F Pool, T F Woolf, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1997
Metabolic disposition of the cognition activator tacrine in rats, dogs, and humans. Species comparisonsW F Pool, M D Reily, S M Bjorge, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 11, 1998
Metabolism and excretion studies in mouse after single and multiple oral doses of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor atorvastatinA E Black, M W Sinz, R N Hayes, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1991
Metabolism of the acyl-CoA:cholesterol acyltransferase inhibitor 2,2-dimethyl-N-(2,4,6-trimethoxyphenyl)dodecanamide in rat and monkey. Omega-/beta-oxidation pathwayT F Woolf, S M Bjorge, A E Black, et al.
British Journal of Clinical Pharmacology|July 1, 1994
The effect of enzyme inhibition on the metabolism and activation of tacrine by human liver microsomesV Spaldin, S Madden, W F Pool, et al.
Biochemical Pharmacology|June 8, 2001
Troglitazone quinone formation catalyzed by human and rat CYP3A: an atypical CYP oxidation reactionK He, T F Woolf, E K Kindt, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 1, 1996
The effect of cytochromes P4501A induction and inhibition on the disposition of the cognition activator tacrine in rat hepatic preparationsS Bezek, M Kukan, W F Pool, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 1, 1994
Metabolic disposition of tacrine in primary suspensions of rat hepatocyte and in single-pass perfused liver: in vitro/in vivo comparisonsM Kukan, S Bezek, W F Pool, et al.
Biochemical Pharmacology|July 6, 1993
An investigation into the formation of stable, protein-reactive and cytotoxic metabolites from tacrine in vitro. Studies with human and rat liver microsomesS Madden, T F Woolf, W F Pool, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1990
Metabolic disposition of trimetrexate, a nonclassical dihydrofolate reductase inhibitor, in rat and dogB K Wong, T F Woolf, T Chang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1994
Stereoselective hydroxylation of tacrine in rats and humansW D Hooper, W F Pool, T F Woolf, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1997
Metabolic disposition of the cognition activator tacrine in rats, dogs, and humans. Species comparisonsW F Pool, M D Reily, S M Bjorge, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 11, 1998
Metabolism and excretion studies in mouse after single and multiple oral doses of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor atorvastatinA E Black, M W Sinz, R N Hayes, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1991
Metabolism of the acyl-CoA:cholesterol acyltransferase inhibitor 2,2-dimethyl-N-(2,4,6-trimethoxyphenyl)dodecanamide in rat and monkey. Omega-/beta-oxidation pathwayT F Woolf, S M Bjorge, A E Black, et al.
British Journal of Clinical Pharmacology|July 1, 1994
The effect of enzyme inhibition on the metabolism and activation of tacrine by human liver microsomesV Spaldin, S Madden, W F Pool, et al.
Biochemical Pharmacology|June 8, 2001
Troglitazone quinone formation catalyzed by human and rat CYP3A: an atypical CYP oxidation reactionK He, T F Woolf, E K Kindt, et al.
Pageof 4